Uni-Bio Science Group Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	525	687	358	452	458	533
Market Cap Growth	10.00%	91.67%	-20.75%	-1.35%	-14.08%	-27.43%
Enterprise Value	430	606	272	363	366	435
Last Close Price	0.09	0.11	0.06	0.07	0.07	0.08
PE Ratio	5.64	7.36	4.33	6.38	11.90	-
PS Ratio	0.90	1.17	0.65	0.93	1.04	1.51
PB Ratio	1.27	1.66	1.10	1.76	2.35	3.06
P/TBV Ratio	1.28	1.67	1.11	1.78	2.39	3.13
P/FCF Ratio	14.37	18.78	12.48	11.56	22.65	147.83
P/OCF Ratio	5.92	7.73	5.37	4.57	9.42	44.29
EV/Sales Ratio	0.73	1.03	0.49	0.75	0.83	1.23
EV/EBITDA Ratio	3.74	5.60	2.42	3.93	6.14	39.96
EV/EBIT Ratio	4.41	6.23	2.73	4.49	7.74	-
EV/FCF Ratio	11.75	16.58	9.46	9.29	18.08	120.49
Debt / Equity Ratio	0.25	0.25	0.37	0.24	0.12	0.03
Debt / EBITDA Ratio	0.90	0.90	1.03	0.63	0.35	0.36
Debt / FCF Ratio	2.82	2.82	4.20	1.58	1.13	1.55
Net Debt / Equity Ratio	-0.23	-0.23	-0.20	-0.31	-0.44	-0.49
Net Debt / EBITDA Ratio	-0.88	-0.88	-0.57	-0.86	-1.44	-7.79
Net Debt / FCF Ratio	-2.62	-2.62	-2.24	-2.04	-4.24	-23.48
Asset Turnover	1.07	1.07	1.19	1.38	1.57	1.36
Inventory Turnover	2.79	2.79	2.62	2.62	2.87	2.72
Quick Ratio	2.79	2.79	2.06	1.70	1.85	1.76
Current Ratio	3.23	3.23	2.58	2.07	2.22	2.19
Return on Equity (ROE)	25.26%	25.26%	28.41%	31.37%	20.87%	-10.77%
Return on Assets (ROA)	11.07%	11.07%	13.43%	14.39%	10.54%	-1.16%
Return on Invested Capital (ROIC)	28.16%	30.89%	41.26%	52.77%	42.34%	-4.70%
Return on Capital Employed (ROCE)	20.40%	20.40%	25.30%	27.40%	23.40%	-2.80%
Earnings Yield	17.76%	13.59%	23.10%	15.68%	8.40%	-3.67%
FCF Yield	6.96%	5.33%	8.01%	8.65%	4.41%	0.68%
Dividend Yield	3.56%	2.82%	4.96%	-	-	-
Buyback Yield / Dilution	2.75%	2.75%	3.53%	-0.07%	0.17%	0.57%
Total Shareholder Return	6.31%	5.57%	8.48%	-0.07%	0.17%	0.57%